Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

July 1, 2017; Volume 58,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Raijmakers, Pieter G.H.M.

    1. You have access
      Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases
      Merijn Joling, Chris Vriend, Odile A. van den Heuvel, Pieter G.H.M. Raijmakers, Paul A. Jones, Henk W. Berendse and Jan Booij
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.116.182139
  2. Rauscher, Isabel

    1. You have access
      Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
      Ingo Einspieler, Isabel Rauscher, Charlotte Düwel, Markus Krönke, Christoph Rischpler, Gregor Habl, Sabrina Dewes, Armin Ott, Hans-Jürgen Wester, Markus Schwaiger, Tobias Maurer and Matthias Eiber
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1081-1087; DOI: https://doi.org/10.2967/jnumed.116.184457
  3. Reddin, Janet S.

    1. You have access
      Qualification of National Cancer Institute–Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
      Joshua S. Scheuermann, Janet S. Reddin, Adam Opanowski, Paul E. Kinahan, Barry A. Siegel, Lalitha K. Shankar and Joel S. Karp
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1065-1071; DOI: https://doi.org/10.2967/jnumed.116.186759
  4. Reiner, Thomas

    1. You have access
      Molecular Imaging of PARP
      Brandon Carney, Susanne Kossatz and Thomas Reiner
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1025-1030; DOI: https://doi.org/10.2967/jnumed.117.189936
  5. Reinhardt, Michael

    1. You have access
      18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi
      Jessica Lohrke, Holger Siebeneicher, Markus Berger, Michael Reinhardt, Mathias Berndt, Andre Mueller, Marion Zerna, Norman Koglin, Felix Oden, Marcus Bauser, Matthias Friebe, Ludger M. Dinkelborg, Joachim Huetter and Andrew W. Stephens
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1094-1099; DOI: https://doi.org/10.2967/jnumed.116.188896
  6. Reynes-llompart, Gabriel

    1. You have access
      Performance Characteristics of the Whole-Body Discovery IQ PET/CT System
      Gabriel Reynés-Llompart, Cristina Gámez-Cenzano, Inmaculada Romero-Zayas, Laura Rodríguez-Bel, José L. Vercher-Conejero and Josep M. Martí-Climent
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1155-1161; DOI: https://doi.org/10.2967/jnumed.116.185561
  7. Riaz, Nadeem

    1. You have access
      Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
      Milan Grkovski, Heiko Schöder, Nancy Y. Lee, Sean D. Carlin, Bradley J. Beattie, Nadeem Riaz, Jonathan E. Leeman, Joseph A. O’Donoghue and John L. Humm
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1072-1080; DOI: https://doi.org/10.2967/jnumed.116.188649
  8. Riedinger, Alina Berriolo

    1. You have access
      Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
      Pierre Vera, Sébastien Thureau, Philippe Chaumet-Riffaud, Romain Modzelewski, Pierre Bohn, Maximilien Vermandel, Sébastien Hapdey, Amandine Pallardy, Marc-André Mahé, Marie Lacombe, Pierre Boisselier, Sophie Guillemard, Pierre Olivier, Veronique Beckendorf, Naji Salem, Nathalie Charrier, Enrique Chajon, Anne Devillers, Nicolas Aide, Serge Danhier, Fabrice Denis, Jean-Pierre Muratet, Etienne Martin, Alina Berriolo Riedinger, Helène Kolesnikov-Gauthier, Eric Dansin, Carole Massabeau, Fredéric Courbon, Marie-Pierre Farcy Jacquet, Pierre-Olivier Kotzki, Claire Houzard, Francoise Mornex, Laurent Vervueren, Amaury Paumier, Philippe Fernandez, Mathieu Salaun and Bernard Dubray
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1045-1053; DOI: https://doi.org/10.2967/jnumed.116.188367
  9. Riou, Laurent M.

    1. You have access
      Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1–5 SPECT in ApoE−/− Mice Fed the Paigen Diet
      Laurent S. Dumas, François Briand, Romain Clerc, Emmanuel Brousseau, Christopher Montemagno, Mitra Ahmadi, Sandrine Bacot, Audrey Soubies, Pascale Perret, Laurent M. Riou, Nick Devoogdt, Tony Lahoutte, Gilles Barone-Rochette, Daniel Fagret, Catherine Ghezzi, Thierry Sulpice and Alexis Broisat
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1088-1093; DOI: https://doi.org/10.2967/jnumed.116.177279
  10. Rischpler, Christoph

    1. You have access
      Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
      Ingo Einspieler, Isabel Rauscher, Charlotte Düwel, Markus Krönke, Christoph Rischpler, Gregor Habl, Sabrina Dewes, Armin Ott, Hans-Jürgen Wester, Markus Schwaiger, Tobias Maurer and Matthias Eiber
      Journal of Nuclear Medicine July 1, 2017, 58 (7) 1081-1087; DOI: https://doi.org/10.2967/jnumed.116.184457
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 58 (7)
Journal of Nuclear Medicine
Vol. 58, Issue 7
July 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi
  • Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
  • Forward to the Past: The Case for Quantitative PET Imaging
  • The Future of Radioligand Therapy: α, β, or Both?
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire